COGT Cogent Biosciences, Inc.
Healthcare · Market cap: $5.0B
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $9.9M | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $9.6M | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $332.5K | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $25.0M | $0 |
| 2025-Q4 | $0 | $12.2M |
| 2026-Q1 | $0 | $370.0M |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $1.7M |
| 2026-Q4 | $0 | $0 |
Bought$44.8M4 buy days
Sold$383.9M7 sell days
Net insider flow-$339.1Mnet selling · 5 years
Latest trade2026-08-27Morris Arlene
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-08-27 | Sell | Morris Arlene | Director | 45,510 | $37.12 | $1.7M | 2 |
| 2026-03-31 | Sell | Fairmount Funds Management LLC | Director | 7,000,000 | $34.66 | $242.6M | 1 |
| 2026-01-22 | Sell | Fairmount Funds Management LLC | Director | 3,500,000 | $36.40 | $127.4M | 1 |
| 2025-12-26 | Sell | Robinson John Edward | Other C-suite | 90,000 | $38.74 | $3.5M | 1 |
| 2025-12-26 | Sell | Sachs Jessica | Other C-suite | 82,642 | $38.70 | $3.2M | 1 |
| 2025-12-26 | Sell | Green John L. | CFO | 77,000 | $38.68 | $3.0M | 1 |
| 2025-12-26 | Sell | Kearns Evan | Other C-suite | 65,000 | $38.70 | $2.5M | 1 |
| 2025-07-10 | Buy | Fairmount Funds Management LLC | Director | 2,777,777 | $9.00 | $25.0M | 1 |
| 2025-01-14 | Buy | Pinnow Cole | Other C-suite | 43,750 | $7.60 | $332.5K | 1 |
| 2023-06-09 | Buy | Fairmount Funds Management LLC | 10% owner | 800,000 | $12.00 | $9.6M | 1 |
| 2022-06-16 | Buy | Fairmount Funds Management LLC | 10% owner | 1,200,000 | $8.25 | $9.9M | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Fairmount Funds Management LLC | Director | $44.5M | $370.0M | 2026-03-31 |
| Robinson John Edward | Other C-suite | $0 | $3.5M | 2025-12-26 |
| Sachs Jessica | Other C-suite | $0 | $3.2M | 2025-12-26 |
| Green John L. | CFO | $0 | $3.0M | 2025-12-26 |
| Kearns Evan | Other C-suite | $0 | $2.5M | 2025-12-26 |
| Morris Arlene | Director | $0 | $1.7M | 2026-08-27 |
| Pinnow Cole | Other C-suite | $332.5K | $0 | 2025-01-14 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2018-04-03 | 4 | $6.7M | 45 | -3.5% (+0.1% raw) | +29.8% (+36.7% raw) | -19.4% (-4.8% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.